Literature DB >> 26527831

Muir-Torre syndrome.

Danielle Mintsoulis1, Jennifer Beecker2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26527831      PMCID： PMC4786404          DOI： 10.1503/cmaj.150171

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.

Authors:  Giovanni Ponti; Andrea Meschieri; Annamaria Pollio; Cristel Ruini; Marco Manfredini; Caterina Longo; Victor D Mandel; Silvana Ciardo; Aldo Tomasi; Luca Giannetti; Giovanni Pellacani
Journal:  J Oral Pathol Med       Date:  2014-09-12       Impact factor: 4.253

2.  Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects.

Authors:  Francesca Duraturo; Raffaella Liccardo; Angela Cavallo; Marina De Rosa; Michela Grosso; Paola Izzo
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

3.  Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development.

Authors:  T Graefe; U Wollina; H Schulz; W Burgdorf
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 4.  Sebaceous lesions and their associated syndromes: part I.

Authors:  Daniel B Eisen; Daniel J Michael
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

5.  New facial papules in a 66-year-old woman with bladder cancer.

Authors:  Radhika N Nakrani; Arunima Ghosh; Chyi-Chia Richard Lee; Piyush K Agarwal; Andrea B Apolo; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2014-08-07       Impact factor: 11.527
  5 in total
  1 in total

Review 1.  Periocular dermatoses.

Authors:  P Chang; G Moreno-Coutiño
Journal:  Int J Womens Dermatol       Date:  2017-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.